home / stock / nspr / nspr news

NSPR News and Press, InspireMD Inc. From 03/02/21

Stock Information
Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com
Menu
NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...
NSPR - InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update

TEL AVIV, Israel, March 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) (“InspireMD” or the “Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), tod...
NSPR - InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States

TEL AVIV, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that it has engaged Hart Clinical Consultants (HCC), a le...

NSPR - 5 Penny Stocks To Buy With Up To 219% Upside According To Analysts

Are Analysts Right About These Penny Stocks To Buy? Who’s ready for another busy week with penny stocks ? I know after a short week last week – and a volatile one at that – many are anticipating what to expect this week. Surely we’ll see continued attenti...

NSPR - InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States

TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the appointment of Chris Metzger, M.D., system chair of c...
NSPR - InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

TEL AVIV, Israel, Feb. 08, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin Ame...

NSPR - 5 Cheap Penny Stocks To Buy Under $5, Are They Worth It?

5 Penny Stocks Trading Higher On Friday; Will The Trend Last? Penny Stocks are surging once again on Friday. One of the biggest trends we see in 2021 is the rise of the retail trader. Not only after these traders “broken” the stock market, but they’ve also likel...

NSPR - InspireMD shares slide on pricing upsized $18M securities offering

InspireMD (NSPR) -7.5% premarket on pricing upsized public offering 29,032,258 units at $0.62, for gross proceeds of $18M (or $20.7M if the underwriters exercise their option). Each unit consists one share of common stock and one Series G Warrant to purchase one-half of on...
NSPR - InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering

TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin Ame...

NSPR - InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland China

TEL AVIV, Israel, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today announced a transaction intended to achieve distribution of CGu...

NSPR - InspireMD's CGuard(TM) Featured in Multiple Presentations, Including a Live Case Demonstration During the Leipzig Interventional Congress January 25-29, 2021

TEL AVIV, Israel, Jan. 26, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, announced today multiple presentations regarding CGuard EPS, includin...
Previous 10 Next 10